- Resolve Biosciences Announces Appointment of John Stark as Chief Executive Officer
- Bio-Rad to Participate in Citi’s 2023 Healthcare Services, MedTech, Tools & HCIT Conference
- Bio-Rad Reports Fourth-Quarter and Full-Year 2022 Financial Results
- Bio-Rad to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, February 16, 2023
- Bio-Rad to Present Company Overview at J.P. Morgan 41st Annual Healthcare Conference
More ▼
Key statistics
As of last trade, Bio Rad Laboratories Inc (BIO:NYQ) traded at 472.97, 37.24% above the 52 week low of 344.63 set on Oct 31, 2022.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 469.90 |
---|---|
High | 477.28 |
Low | 469.90 |
Bid | 472.80 |
Offer | 474.36 |
Previous close | 469.87 |
Average volume | 190.75k |
---|---|
Shares outstanding | 29.60m |
Free float | 21.32m |
P/E (TTM) | -- |
Market cap | 13.58bn USD |
EPS (TTM) | -121.14 USD |
Data delayed at least 15 minutes, as of Mar 20 2023 15:24 BST.
More ▼